Merit Medical Systems (MMSI) Stock Overview
Designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
MMSI Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Merit Medical Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$67.51 |
| 52 Week High | US$96.74 |
| 52 Week Low | US$59.74 |
| Beta | 0.53 |
| 1 Month Change | 10.18% |
| 3 Month Change | -3.67% |
| 1 Year Change | -29.06% |
| 3 Year Change | -17.99% |
| 5 Year Change | 8.90% |
| Change since IPO | 1,202.24% |
Recent News & Updates
Narrative Update • Jun 04
MMSI: Margin Strength And 2026 Guidance Reset Will Drive Future Upside
Merit Medical Systems' analyst price target has been reset lower by about $8.82 per share. This change reflects analysts' updated assumptions for slightly softer revenue growth, a modestly lower discount rate, stronger profit margins, and a reduced future P/E multiple.
New Narrative • May 16
Oncology And Endoscopy Platforms Will Reshape Long Term Earnings Power
Catalysts About Merit Medical Systems Merit Medical Systems develops and sells medical devices used in vascular, oncology, cardiac, renal and endoscopy procedures worldwide. What are the underlying business or industry changes driving this perspective?Recent updates
Narrative Update • Jun 04
MMSI: Margin Strength And 2026 Guidance Reset Will Drive Future Upside
Merit Medical Systems' analyst price target has been reset lower by about $8.82 per share. This change reflects analysts' updated assumptions for slightly softer revenue growth, a modestly lower discount rate, stronger profit margins, and a reduced future P/E multiple.New Narrative • May 16
Oncology And Endoscopy Platforms Will Reshape Long Term Earnings Power
Catalysts About Merit Medical Systems Merit Medical Systems develops and sells medical devices used in vascular, oncology, cardiac, renal and endoscopy procedures worldwide. What are the underlying business or industry changes driving this perspective?Seeking Alpha • May 02
Merit Medical Systems: Creating More Growth Engines (Rating Upgrade)
Summary Merit Medical Systems trades at 17-18x earnings with solid fundamentals, moderate leverage, and reasonable valuation, supporting an upbeat outlook. Q1 organic growth was on the lower end, but full-year guidance was maintained and even slightly raised for sales, reflecting recent M&A contributions. Growth engines include the View Point Medical acquisition and WRAPSODY, both expected to accelerate revenue and margin expansion into 2026. Despite softer organic growth and CEO transition, Merit's business remains resilient, with potential for re-rating as growth drivers materialize. Read the full article on Seeking Alpha
New Narrative • May 01
Tariffs And OEM Volatility Will Pressure Margins Yet Long Term Procedure Demand Will Support Progress
Catalysts About Merit Medical Systems Merit Medical Systems develops and sells medical devices used in vascular, oncology, cardiac, renal and endoscopy procedures worldwide. What are the underlying business or industry changes driving this perspective?Narrative Update • Apr 24
MMSI: 2026 Guidance Execution And Margin Resilience Will Drive Future Upside
Analysts have nudged their price targets on Merit Medical slightly lower, with the updated fair value estimate moving from about $101.18 to $98.36 as they factor in modestly softer profit margin assumptions and a somewhat higher future P/E multiple, alongside recent target cuts and a downgrade tied to 2026 guidance uncertainty. Analyst Commentary Recent research on Merit Medical Systems highlights a mix of confidence in the business model and caution around execution against medium term targets, especially the 2026 outlook.Narrative Update • Apr 08
MMSI: 2026 Margin Outlook And Guidance Will Drive Upside Potential
Analysts have trimmed the blended fair value estimate for Merit Medical Systems to about $101 from roughly $104, reflecting a lower projected price target that incorporates higher discount rates, slightly softer revenue growth assumptions, and a more moderate future P/E multiple, even as margin expectations improve. Analyst Commentary Recent Street research on Merit Medical Systems presents a mixed picture, with some analysts trimming targets or ratings on guidance uncertainty, while others still see room for valuation support based on execution and margins.Analysis Article • Dec 31
We Like These Underlying Return On Capital Trends At Merit Medical Systems (NASDAQ:MMSI)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Analysis Article • Jul 14
Calculating The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)
Key Insights The projected fair value for Merit Medical Systems is US$80.02 based on 2 Stage Free Cash Flow to Equity...Analysis Article • Jun 29
If EPS Growth Is Important To You, Merit Medical Systems (NASDAQ:MMSI) Presents An Opportunity
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analysis Article • May 21
Risks To Shareholder Returns Are Elevated At These Prices For Merit Medical Systems, Inc. (NASDAQ:MMSI)
With a price-to-earnings (or "P/E") ratio of 47.8x Merit Medical Systems, Inc. ( NASDAQ:MMSI ) may be sending very...Analysis Article • May 07
We Take A Look At Why Merit Medical Systems, Inc.'s (NASDAQ:MMSI) CEO Has Earned Their Pay Packet
Key Insights Merit Medical Systems will host its Annual General Meeting on 14th of May CEO Fred Lampropoulos' total...Analysis Article • Apr 11
Merit Medical Systems' (NASDAQ:MMSI) Returns On Capital Are Heading Higher
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Analysis Article • Mar 30
Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?
While Merit Medical Systems, Inc. ( NASDAQ:MMSI ) might not have the largest market cap around , it received a lot of...Analysis Article • Mar 18
Here's Why We Think Merit Medical Systems (NASDAQ:MMSI) Is Well Worth Watching
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Seeking Alpha • Mar 16
Merit Medical: A Success Story That Keeps Getting Better
Summary Merit Medical continues to outperform, with the share price supported by on-target financial results, incremental M&A, and positive clinical data. The company's Wrapsody stent graft showed almost best-case clinical efficacy, positioning it to capture significant market share in dialysis graft occlusion procedures. Recent acquisitions, including EsophyX Z+ and Cook Medical’s lead management portfolio, enhance Merit’s product portfolio and offer longer-term synergies. CEO succession remains a concern, but could also prompt a bid for the company. Despite not being "super cheap", Merit’s strong execution, revenue growth, and margin leverage justify a positive rating, with potential for further valuation uplift. Read the full article on Seeking AlphaAnalysis Article • Mar 06
A Look At The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)
Key Insights Merit Medical Systems' estimated fair value is US$100 based on 2 Stage Free Cash Flow to Equity With...Analysis Article • Feb 10
Merit Medical Systems (NASDAQ:MMSI) Seems To Use Debt Rather Sparingly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Analysis Article • Jan 17
Why We're Not Concerned About Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Share Price
With a price-to-earnings (or "P/E") ratio of 49.6x Merit Medical Systems, Inc. ( NASDAQ:MMSI ) may be sending very...Seeking Alpha • Jan 08
Merit Medical Systems: Solid Execution, Stretched Valuations
Summary Merit Medical Systems' stock is up 40% from last spring's lows, driven by strong Q3 results and positive analyst sentiment. The stock's rally has stalled recently. The company has also made a small acquisition in September and garnered a key FDA approval to close out 2024 on a high note. More upside ahead, or will the shares experience further profit-taking? An analysis of Merit Medical Systems follows in the paragraphs below. Read the full article on Seeking AlphaAnalysis Article • Dec 23
Returns Are Gaining Momentum At Merit Medical Systems (NASDAQ:MMSI)
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Analysis Article • Dec 11
Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?
While Merit Medical Systems, Inc. ( NASDAQ:MMSI ) might not have the largest market cap around , it saw a decent share...Analysis Article • Nov 29
Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Analysis Article • Nov 02
Merit Medical Systems, Inc. (NASDAQ:MMSI) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
It's been a good week for Merit Medical Systems, Inc. ( NASDAQ:MMSI ) shareholders, because the company has just...Analysis Article • Nov 01
Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Seeking Alpha • Sep 17
Merit Medical Systems - Impressive Momentum
Summary Merit Medical Systems has shown strong operating momentum this year, driven by organic growth and strategic acquisitions. Founder Fred Lampropoulos plans to retire by the end of 2025, as a well-planned succession alleviates concerns on that front. Recent acquisitions, including EndoGastric Solutions and Cook's Medical portfolio, enhance product offerings but are priced into the current high valuation. Despite positive momentum and trial results, the stock's high valuation warrants a cautious, wait-and-see approach. Read the full article on Seeking AlphaAnalysis Article • Sep 17
The Price Is Right For Merit Medical Systems, Inc. (NASDAQ:MMSI)
Merit Medical Systems, Inc.'s ( NASDAQ:MMSI ) price-to-earnings (or "P/E") ratio of 49.4x might make it look like a...Analysis Article • Sep 04
Why Merit Medical Systems, Inc. (NASDAQ:MMSI) Could Be Worth Watching
Merit Medical Systems, Inc. ( NASDAQ:MMSI ), might not be a large cap stock, but it saw a decent share price growth of...
New Narrative • Aug 29
China Market And New Products Propel Medical Equipment Giant To New Heights
Enhanced international market performance, notably in China, hints at potential market share and revenue increases.Shareholder Returns
| MMSI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 10.9% | 6.1% | -3.3% |
| 1Y | -29.1% | -19.2% | 22.3% |
Return vs Industry: MMSI underperformed the US Medical Equipment industry which returned -20.4% over the past year.
Return vs Market: MMSI underperformed the US Market which returned 22.5% over the past year.
Price Volatility
| MMSI volatility | |
|---|---|
| MMSI Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MMSI has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: MMSI's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 7,500 | Martha Aronson | www.merit.com |
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems.
Merit Medical Systems, Inc. Fundamentals Summary
| MMSI fundamental statistics | |
|---|---|
| Market cap | US$3.94b |
| Earnings (TTM) | US$139.34m |
| Revenue (TTM) | US$1.54b |
28.9x
P/E Ratio2.6x
P/S RatioIs MMSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MMSI income statement (TTM) | |
|---|---|
| Revenue | US$1.54b |
| Cost of Revenue | US$791.39m |
| Gross Profit | US$751.05m |
| Other Expenses | US$611.71m |
| Earnings | US$139.34m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.34 |
| Gross Margin | 48.69% |
| Net Profit Margin | 9.03% |
| Debt/Equity Ratio | 45.2% |
How did MMSI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/09 06:50 |
| End of Day Share Price | 2026/06/09 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Merit Medical Systems, Inc. is covered by 22 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Baird |
| David Rescott | Baird |
| Michael Petusky | Barrington Research Associates, Inc. |